AETHER / Q3-FY26 / claim-ledger

Audit the questions that mattered.

Aether Industries · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ3-FY26 · 2026-01-15Back to quarter ↗

Questions audited

10

Answered directly

85%

Numeric claims

5

Consistency

contradicted

Question ledger

What was answered, and how?

Sajel Kapoor · antifracy thinking

evasive

How does Aether treat talent retention as a core priority?

We spend a lot of time at the management level focusing on this issue. We have attractive ESOPs, packages, incentives across the company. We are very careful in selection of candidates. Surat is a nice city to live in.

Sajel Kapoor · antifracy thinking

direct

How does Aether's culture show up during scale-up experiment failures?

We lead from the top. Our promoter family is a mix of techno-commercial excellence. We have about 50 projects going on in R&D today, all directly led by myself. We have a culture of stop work at all levels.

Pikshit Gujarati · Nishad

direct

Strategy for CM: acquire new customers or gain pocket share?

The answer is both. We work extremely hard in curating relationships with innovators. We want the next 10 products in their pipeline. We are continuously looking for new customers, exhibiting in about 10 shows worldwide.

Pikshit Gujarati · Nishad

direct

Time to convert a customer from CRAMS to CM?

It really depends. Examples from 6 months to 6 years. On average, between one to two years.

Pikshit Gujarati · Nishad

direct

Future revenue contribution from CRAMS/CM vs LSM?

What we're targeting is basically 70% of our revenue coming from CRAMS and CM and 30% coming from large scale manufacturing.

Manishadani · 361 Capital

declined

Name of the new European customer in material science?

We do not name our customers. It's a customer from Europe in the material science sector. We'll not comment anything further.

Deng · Tiger Assets

direct

Entry barriers and pricing pressure in non-pharma non-agro CM?

In the west it's increasingly impossible to manufacture anymore. Pricing has increased significantly in the west. These companies don't typically shop around once they establish strategic partnerships. There is no pricing pressure.

Deng · Tiger Assets

direct

Contract renewal cycle and pricing mechanism?

Contracts are usually for five to ten year minimum, then auto-renewed. Pricings are negotiated every year based on open costing sheet platform.

Kumar Somia · Ambit Capital

partial

Clarity on other CM contracts and Converge Polyol status?

Converge Polyol is picking up very well. A lot of new customers are sampling and have given small quantity orders. One product had a cyclical trend but will turn up good this quarter.

Kumar Somia · Ambit Capital

evasive

Key products driving LSM improvement?

We have several key products on this but we would not like to discuss the products but we can discuss it offline.

Kumar Somia · Ambit Capital

direct

Demand trend in pharma and agro business?

Volumes have increased quarter on quarter 10%, year on year 25% for us. We are seeing good demand. Prices have bottomed out.

Kumar Somia · Ambit Capital

direct

Sustainable EBITDA margin guidance?

We would like to still be conservative and always be around 29 to 30%, not more than that. There's a one-time FLOP claim that has increased margins.